Safety and efficacy of second-generation versus first-generation cryoballoons for treatment of atrial fibrillation: a meta-analysis of current evidence
Authors:
- 18 November 2015
- journal article
- research article
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 45 (1) , 49-56
Abstract
The newer second-generation cryoballoons (CB-2 or Arc-Adv-CB) have been shown to achieve significantly lower temperature and faster pulmonary vein isolation (PVI) time in comparison with first-generation cryoballoons (CB-1 or Arc-CB). To test the premise that second-generation cryoballoons can improve clinical outcomes in comparison to first-generation cryoballoons in terms of safety and efficacy, we pooled data for systemic review and meta-analyses from all available literature comparing their clinical performance. The Cochrane Library, PubMed, Google Scholar, and studies presented at various meetings were searched for any published literature comparing safety and efficacy of the second-generation cryoballoons (Arctic Front Advance cryoballoons) with first-generation cryoballoons (Arctic Front Cryoballoons). A total of ten published studies, with 2310 patients, were included in this meta-analysis with 957 patients in second-generation cryoballoon group and 1237 patients in first-generation cryoballoon group. The pooled analysis showed significant superiority of second-generation cryoballoons in terms of less procedure time, less fluoroscopic time, and fewer incidences of arrhythmia recurrences compared to first-generation cryoballoons at the cost of higher incidence of persistent and transient phrenic nerve palsy. The differences in the rate of pericardial effusion and incidence of access site complications were not statistically significant. Second-generation cryoballoons are associated with a shorter procedure time and fluoroscopy time, along with lower arrhythmia recurrence rates, reflecting higher procedure efficacy when compared to first-generation cryoballoons. However, they are also associated with a higher incidence of transient and persistent phrenic nerve palsies with a non-significant difference in rates of access site complications and pericardial effusion.Keywords
This publication has 19 references indexed in Scilit:
- Incidence and characteristics of phrenic nerve palsy following pulmonary vein isolation with the second-generation as compared with the first-generation cryoballoon in 360 consecutive patientsEP Europace, 2015
- Second Generation of Cryoballoons Can Improve Efficiency of Cryoablation for Atrial FibrillationPacing and Clinical Electrophysiology, 2014
- Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second-generation cryoballoonEP Europace, 2014
- Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort SubstudyEP Europace, 2014
- Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillationHeart Rhythm, 2014
- Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: A comparison between the first- and second-generation balloonHeart Rhythm, 2013
- Improved Procedural Efficacy of Pulmonary Vein Isolation Using the Novel Second‐Generation CryoballoonJournal of Cardiovascular Electrophysiology, 2012
- Long-Term Outcome After Successful Catheter Ablation of Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2010
- Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2009
- Circumferential Pulmonary Vein Isolation With the Cryoballoon TechniqueJACC, 2008